Leniolisib: a drug providing a promising avenue for the treatment of activated phosphoinositide 3-kinase δ syndrome (APDS)

Ann Med Surg (Lond). 2024 May 20;86(7):3812-3813. doi: 10.1097/MS9.0000000000002189. eCollection 2024 Jul.
No abstract available

Publication types

  • Editorial